News

By Lívia Honório de Figueiredo

Life sciences patent eligibility in Latin America: a guide

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that should be pursued by life sciences companies is building and maintaining a patent portfolio capable of distinguishing itself from competitors, as well as representing a well-reasoned business strategy. Companies should secure their patent assets by maximising patent coverage of the core technology and its potential improvements. One reason is that patents can demonstrate the commercial potential of a company’s technology, they are also the driving force for major events in the lifecycle of a life sciences company.

Access the full guide, published by IAM and written by Priscila Kashiwabara, Marisa Momoli and Livia Figueiredo by clicking here.
Back

Last by Lívia Honório de Figueiredo

September 9, 2024

Kasznar Leonardos wins LMG Life Sciences

We are honored to announce that Kasznar Leonardos has won the Firm of the Year: Brazil award at the LMG Life Sciences! Kasznar Leonardos wins LMG Life Sciences

Ler notícia

May 4, 2023

Kasznar Leonardos attends the BIO International Convention

Our specialists Lívia Figueiredo and Jansen Viana are set to attend the BIO International Convention, which will take place from June 5-8, 2023, Kasznar Leonardos attends the BIO International Convention

Ler notícia

April 24, 2023

“Brazil: The patent combination conundrum” for LSIPR Magazine

Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common “Brazil: The patent combination conundrum” for LSIPR Magazine

Ler notícia
plugins premium WordPress